{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:50:17Z","timestamp":1779879017305,"version":"3.53.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/mph.0000000000000389","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T21:30:55Z","timestamp":1436650255000},"page":"560-565","source":"Crossref","is-referenced-by-count":10,"title":["Improvement in the Outcome of Invasive Aspergillosis in a Pediatric Hematology Department"],"prefix":"10.1097","volume":"37","author":[{"given":"Carine","family":"Domenech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charline","family":"Leick-Courtois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Pracros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Picot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bleyzac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210209","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/313445","article-title":". Aspergillosis in children with cancer: a 34-year experience.","volume":"29","author":"Abbasi","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R2-14-20210209","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMra0808853","article-title":"Aspergillosis.","volume":"360","author":"Segal","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-14-20210209","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":". Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.","volume":"44","author":"Upton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R4-14-20210209","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1439-0507.2007.01449.x","article-title":". Invasive aspergillosis in a paediatric haematology department: a 15-year review.","volume":"51","author":"Crassard","year":"2008","journal-title":"Mycoses"},{"key":"R5-14-20210209","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1399-3062.2008.00304.x","article-title":". Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience.","volume":"10","author":"Crassard","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"R6-14-20210209","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2005-1161","article-title":"Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.","volume":"117","author":"Zaoutis","year":"2006","journal-title":"Pediatrics"},{"key":"R7-14-20210209","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2334-7-28","article-title":". Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients.","volume":"7","author":"Cesaro","year":"2007","journal-title":"BMC Infect Dis"},{"key":"R8-14-20210209","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","article-title":". Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases.","volume":"121","author":"Burgos","year":"2008","journal-title":"Pediatrics"},{"key":"R9-14-20210209","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/MPH.0b013e3181acd956","article-title":". Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade.","volume":"31","author":"Rubio","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R10-14-20210209","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1439-0507.1999.00496.x","article-title":". Five-year survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival.","volume":"42","author":"Groll","year":"1999","journal-title":"Mycoses"},{"key":"R11-14-20210209","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":". Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of CancerInvasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTCMSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R12-14-20210209","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":". Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol"},{"key":"R13-14-20210209","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":". Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R14-14-20210209","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3324\/haematol.2014.103507","article-title":". Dexamethasone (6 mgm2day) and prednisolone (60 mgm2day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial.","volume":"99","author":"Domenech","year":"2014","journal-title":"Haematologica"},{"key":"R15-14-20210209","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/sj.leu.2403932","article-title":". Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report.","volume":"19","author":"Entz-Werle","year":"2005","journal-title":"Leukemia"},{"key":"R16-14-20210209","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.ejca.2008.08.007","article-title":". First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study.","volume":"44","author":"Domenech","year":"2008","journal-title":"Eur J Cancer"},{"key":"R17-14-20210209","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/pbc.20706","article-title":". Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.","volume":"47","author":"Brunet","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R18-14-20210209","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/INF.0b013e3181da2171","article-title":". A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.","volume":"29","author":"Maertens","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R19-14-20210209","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1128\/AAC.00873-06","article-title":". Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.","volume":"51","author":"Meletiadis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-14-20210209","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.mph.0000155861.38641.ca","article-title":". Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution.","volume":"27","author":"Rosen","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"R21-14-20210209","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00277-002-0599-4","article-title":". Clinical applicability of the new EORTCMSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis.","volume":"82","author":"Subira","year":"2003","journal-title":"Ann Hematol"},{"key":"R22-14-20210209","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1469-0691.2010.03336.x","article-title":"Diagnosis of invasive fungal infections in immunocompromised children.","volume":"16","author":"Dornbusch","year":"2010","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:47:08Z","timestamp":1620964028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201510000-00014"}},"subtitle":["A 10-Year Review"],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000389","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}